Health Technology Assessment

Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis

  • Type:
    Extended Research Article
  • Authors:
    Dalziel K, Round A, Stein K, Garside R, Price A.
  • Journal:
    Health Technology Assessment
  • Issue:
    Volume: 8, Issue: 28
  • Published:
  • Citation:
    Dalziel K, Round A, Stein K, Garside R, Price A. Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis. Health Technol Assess 2004;8(28). https://doi.org/10.3310/hta8280
  • DOI:
    https://doi.org/10.3310/hta8280
Crossmark status check

Toolkit

View Award

The full text of this issue is available as a PDF document from the Toolkit section on this page

We are currently working on improvements to this feature. Please check back soon for updates